Dysferlinopathies: Clinical and genetic variability

Clin Genet. 2022 Dec;102(6):465-473. doi: 10.1111/cge.14216. Epub 2022 Sep 6.

Abstract

Dysferlinopathies are a clinically heterogeneous group of diseases caused by mutations in the DYSF gene encoding the dysferlin protein. Dysferlin is mostly expressed in muscle tissues and is localized in the sarcolemma, where it performs its main function of resealing and maintaining of the integrity of the cell membrane. At least four forms of dysferlinopathies have been described: Miyoshi myopathy, limb-girdle muscular dystrophy type 2B, distal myopathy with anterior tibial onset, and isolated hyperCKemia. Here we review the clinical features of different forms of dysferlinopathies and attempt to identify genotype-phenotype correlations. Because of the great clinical variability and rarety of the disease and mutations little is known, how different phenotypes develop as a result of different mutations. However, missense mutations seem to induce more severe disease than LoF, which is typical for many muscle dystrophies. The role of several specific mutations and possible gene modifiers is also discussed in the paper.

Keywords: Miyoshi myopathy; dysferlin; dysferlinopathies; genotype-phenotype correlations; girdle-limb muscular dystrophy type 2B.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Distal Myopathies*
  • Dysferlin / genetics
  • Humans
  • Membrane Proteins / genetics
  • Muscle Proteins / genetics
  • Muscular Dystrophies, Limb-Girdle* / genetics
  • Mutation

Substances

  • Dysferlin
  • Muscle Proteins
  • Membrane Proteins

Supplementary concepts

  • Dysferlinopathy